252 related articles for article (PubMed ID: 7663310)
1. Health promotion in the work-place--beyond an ethnocentric perspective.
Klingemann HK
Addiction; 1995 Jul; 90(7):877-81. PubMed ID: 7663310
[No Abstract] [Full Text] [Related]
2. Charting the sea of employee addiction.
Russo V; Halpern Z
Occup Health Saf; 1992 Dec; 61(12):35-6, 65. PubMed ID: 1475070
[No Abstract] [Full Text] [Related]
3. An optimistic view from the corporate perspective.
Baase C
Am J Health Promot; 2001; 15(5):363-5. PubMed ID: 11502021
[No Abstract] [Full Text] [Related]
4. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
Miller TR; Zaloshnja E; Spicer RS
Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
[TBL] [Abstract][Full Text] [Related]
5. Poison in party pills is too much to swallow.
Cole M
Nature; 2011 Jun; 474(7351):253. PubMed ID: 21677705
[No Abstract] [Full Text] [Related]
6. Drug screening in the workplace: use, abuse and implications.
Grabowski J; Silverman PB
NIDA Res Monogr; 1989; 95():225-31. PubMed ID: 2640968
[No Abstract] [Full Text] [Related]
7. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening.
George S; Braithwaite RA
Addiction; 1995 Feb; 90(2):227-32. PubMed ID: 7703816
[TBL] [Abstract][Full Text] [Related]
8. Research on drugs and the workplace: introduction and summary.
Gust SW; Crouch DJ; Walsh JM
NIDA Res Monogr; 1990; 100():3-8. PubMed ID: 2132776
[No Abstract] [Full Text] [Related]
9. Survey of employer anti-drug programs.
Hayghe H
NIDA Res Monogr; 1990; 100():177-207. PubMed ID: 2132771
[No Abstract] [Full Text] [Related]
10. The analysis of policy: understanding the process of policy development.
Ryder D
Addiction; 1996 Sep; 91(9):1265-70. PubMed ID: 8854357
[TBL] [Abstract][Full Text] [Related]
11. College on Problems of Drug Dependence Policy on Administering Drugs with Abuse Potential in Human Research.
Drug Alcohol Depend; 1996 Dec; 43(1-2):115-7. PubMed ID: 8957150
[No Abstract] [Full Text] [Related]
12. [Other countries, other drug abuse? Drug dependence and approaches for controlling drug abuse as a global issue].
Knauer RH
Fortschr Med; 1997 Mar; 115(7):48-9. PubMed ID: 9173022
[No Abstract] [Full Text] [Related]
13. [Evaluation of objectives and implementation of services of a combined program for prevention and health promotion].
Desjardins N; Kishchuk N; Lamoureux MC
Can J Commun Ment Health; 1994; 13(2):145-61. PubMed ID: 10172304
[No Abstract] [Full Text] [Related]
14. Health promotion in the workplace: alcohol and drug abuse. Report of a WHO Expert Committee.
World Health Organ Tech Rep Ser; 1993; 833():1-34. PubMed ID: 8367980
[No Abstract] [Full Text] [Related]
15. [Occupational health promotion as a focus of interest of public health institutions and organizations].
Ott-Gerlach G
Offentl Gesundheitswes; 1991 Aug; 53 Suppl 1():69-73. PubMed ID: 1835782
[TBL] [Abstract][Full Text] [Related]
16. Work-site health promotion programs need analysis of cost-effectiveness.
Chenoweth D
Occup Health Saf; 1990 Apr; 59(4):25, 95. PubMed ID: 2110641
[No Abstract] [Full Text] [Related]
17. The status of health promotion programs at the worksite--a review.
Marcotte B; Price JH
Health Educ; 1983; 14(4):4-9. PubMed ID: 6443930
[No Abstract] [Full Text] [Related]
18. [The hospital, a site for prevention? From prevention of drug dependence to general drug promotion].
Fleischmann H; Lenske H
Gesundheitswesen; 1996 Jun; 58(6):315-8. PubMed ID: 8766845
[TBL] [Abstract][Full Text] [Related]
19. Public policy statement on national drug policy. American Society of Addiction Medicine.
J Addict Dis; 1994; 13(4):231-4. PubMed ID: 7734471
[No Abstract] [Full Text] [Related]
20. A corporate perspective from Lucent Technologies: reflections from the economic buyer of health promotion programs--what really matters to me and my boss?
Shoner LG; Cioffi L
Am J Health Promot; 2001; 15(5):361-2. PubMed ID: 11502020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
